Ubiquitin-like (Ubl) modifications regulate nearly all cellular functions in eukaryotes with the largest superfamily of Ubl-specific proteases being Cys proteases. SENP1 is a model for this protease family and responsible for processing SUMO. Here, using NMR relaxation measurements, chemical shift perturbation, and enzyme kinetic analysis, we provide structural insights into the mechanism of substrate recognition coupled enzymatic activation within SENP1. We find that residues in the catalytic channel of SENP1, including the “lid” residue Trp465, exhibit dynamics over a range of timescales, both in the presence and absence of bound substrates. The β-grasp domain of SUMO1 alone induces structural changes at ~20 Å away in the active site of SENP1, revealing the importance of this domain in activating the enzyme. These findings likely represent general properties of the mechanism of substrate recognition and processing by SENPs and other Ubl-specific proteases, and illuminate how adaptive substrate binding can allosterically enhance enzyme activity.
Ubiquitin-like (Ubl) modifications play essential roles in cellular regulation in eukaryotes, and Cys proteases form the largest superfamily of Ubl-specific proteases 1. All small ubiquitin-like modifier (SUMO)-specific proteases belong to this family, as do at least four types of de-ubiquitination enzymes (DUBs)—ubiquitin-specific proteases (USP), ovarian tumor proteases (OTU), Machado-Josephin domain proteases (MJD), and the ubiquitin C-terminal hydrolases (UCH) 2. Ubls, such as ubiquitin and SUMO, are first synthesized as precursor proteins that are cleaved by Ubl-specific proteases to expose their C-terminal Gly-Gly motif. After being cleaved, a Ubl is conjugated to other cellular proteins through the functions of three enzymes—generally known as E1, E2 and E3 3-5. Ubl-specific proteases also remove Ubls from modified proteins when regulating these dynamic modifications. SUMO-specific proteases include SENP1, 2, 3, 5, 6 and 7, and USPL1 6,7. These Cys proteases have similar biochemical mechanisms, and available crystal structures have revealed common structural features at their catalytic centers. These previous studies have also inspired some general questions regarding their catalytic mechanisms. First, the catalytic Cys residues are located within the closed catalytic channels for binding the C-termini of Ubls (Fig. 1A, Supplementary Fig. 1) 8-15. In all SENPs, an aromatic sidechain, such as that of Trp or Phe, forms the channel “lid” (Fig. 1A, Supplementary Fig. 1). It remains unclear how substrates bind into the closed catalytic channels to reach the catalytic Cys. Second, the catalytic residues undergo conformational changes when these proteases form complexes with their substrates 12,13,16,17. The mechanisms for rearranging the catalytic residues are not well understood.
SENP1 is a model system for the Ubl-specific proteases in the Cys protease superfamily because it shares the same biochemical mechanism and its catalytic Cys is similarly buried as those of other Ubl-specific proteases (Fig. 1A, Supplementary Fig. 1) 10-14. In addition, SENP1 is an essential gene and is a potential target for developing new therapeutic agents for cancer. SENP1 plays a key role in tumor angiogenesis, because it regulates the stability of hypoxia-inducible factor 1α (HIF1α), which is a key player in the formation of new blood vessels to support tumor growth 18,19. SENP1 is also highly expressed in human prostate cancer specimens and regulates androgen receptor (AR) activities 20-22. Similarly, many Ubl-specific proteases are targets for developing therapies for life-threatening diseases such as cancer, neurodegenerative disorders, and infectious diseases 20,21,23-25. Despite the availability of many crystal structures, it has been challenging to develop competitive inhibitors that target the catalytic channel 26, suggesting that a better understanding of these enzymes and their interactions with substrates is necessary.
To address some of the outstanding questions for this class of enzymes, we performed NMR studies on SENP1 in combination with enzyme kinetic analysis. Although crystal structures show the catalytic channel of SENP1 to be closed, we find that these residues exhibit extensive motions that likely reflect open-closed dynamics; moreover, these dynamics persist in the presence of bound substrate. In addition, we have found that the distally bound β-grasp domain of SUMO1 induces realignment of the catalytic residues that enhance the enzyme activity. Similar enhancement has also been observed for a DUB, USP5. We suggest that the mode of substrate recognition and binding we observed for SENP1 maybe shared by other de-Ubl enzymes.
RESULTS
Conformational dynamics of the catalytic channel
Although crystal structures show that the catalytic Cys residue of SENP1 is located within closed catalytic channel (Fig. 1A) 13,14, extensive conformational flexibility on the μs-ms timescale is apparent for residues at the catalytic channel based on their severely broadened resonances in the 1H-15N HSQC spectra (Fig. 1B). These spectra and other data were obtained with the catalytically inactive C603S mutant of SENP1 catalytic domain in order to compare the free enzyme with enzyme-substrate complexes as discussed below. Similar flexibility is expected for the wild-type SENP1, because severe line broadening was observed for the amide resonances of the residues at the catalytic channel, including Trp534 (Supplementary Fig. 2) and residues 464-466, whose amide resonances were too broad to be observed in 1H-15N HSQC spectrum. These dynamics were characterized by measuring the 15N R1, R2, 1H-15N nuclear Overhauser effect (NOE) and HzNz R1ρ relaxation rates, as well as 15N and 13C-methyl Carr-Purcell-Meiboom-Gill (CPMG)-transverse relaxation dispersion for the C603S mutant (Supplementary Tables 1-4 and Supplementary 3). These measurements were designed to provide quantitative information of dynamics over a wide range of timescales. 1H-15N NOE and 15N R1 rates are sensitive to motions on the ps-ns timescale that reflects the conformational entropy of the system, while Rex of HzNz R1ρ detect dynamics on the μs timescale 27. CPMG relaxation dispersion provides insights into conformational dynamics on a timescale (μs-ms) slower than what can be detected by R1ρ. Protein dynamics in the μs-ms timescale are associated with molecular recognition and enzyme catalysis. The slower the dynamics, the higher the energy barrier of the changes between the different conformational states according to thermal dynamic principles.
Relaxation measurements on free SENP1 reveal that the catalytic channel of SENP1 undergoes extensive dynamics over a wide range of timescales. The catalytic channel lid Trp465 undergoes motions over the widest timescales, from ps to ms, among detectable resonances of residues at the catalytic channel, also consistent with its broadened amide resonances (Fig. 1B). Fast motions in the ps-ns timescale regime for Trp465 are indicated by 1H-15N NOE values (Table S3) less than the theoretical maximum (~0.83 at 600 MHz spectrometer frequency) were observed for the Trp465 (0.66 for the backbone N and 0.57 for the sidechain Nε, Supplementary Table 3). In addition, significant motions in the μs timescale were detected by HzNz R1ρ measurements (Supplementary Table 4) 27. Furthermore, 15N-CPMG dispersions were observed for both Trp465 N and Nε groups by 600 and 700 MHz NMR instruments, indicating dynamics in the μs-ms timescale (Figs. 1C). The CPMG dispersion profiles of the Trp465 backbone and sidechain did not plateau at the highest CPMG field strength (Fig. 1C), consistent with the motions detected for this residue by HzNz R1ρ. Trp534 at the bottom of the catalytic channel undergoes μs-ms timescale dynamics, as indicated by 15N-CPMG dispersion for Nε by the 600 and 700 MHz NMR instruments (Figs. 1A, 1C). His533, which is involved in catalysis, and Leu530, which is near His533, undergo μs timescale motions as indicated by the large Rex values obtained from HzNz R1ρ measurements (Supplementary Table 4, Fig. 1A). The fast motions of His533 suggest that it is susceptible to conformational changes.
SENP1 interaction with substrates
The substrate SUMO1 consists of a β-grasp domain that encompasses residues 20-92 and a flexible C-terminus that begins with residue 93 in the SUMO1 precursor (referred to as SUMO1-FL, residues 1-101) or in mature SUMO1 (referred to as SUMO-GG, residues 1-97) that is the product of SENP1 cleavage. Both the β-grasp domain and the unstructured C-terminus interact with SENPs in the crystal structures of their complexes with SUMO precursors or conjugated substrates 10-14. We compared SENP1 interactions with SUMO1-FL, SUMO1-GG, SUMO11-92 (containing residues 1-92, with C-terminus truncated) or peptides corresponding to the C-terminus of SUMO1. Each of these SUMO1 constructs was titrated into 15N or 13C-methyl-labeled SENP1, and NMR chemical shift perturbation (CSP) was monitored in a series of two-dimensional 1H-15N HSQC or 1H-13C HMQC correlation spectra (Fig. 2A-D, and 2F-G, and Supplementary Fig. 4). The exchange rates between free SENP1 and SENP1 in complex with SUMO1-FL or SUMO1-GG were mostly slow to intermediate, relative to the NMR chemical shift timescale, and both SUMO-GG and SUMO-FL produced similar CSP (Fig. 2B). Upon titration with SUMO11-92, the resonances of some residues (i.e., R449, Fig. 2C and Supplementary Fig. 4) showed similarly slow exchange between free and bound states and similar CSP as that observed for binding of SUMO1-FL or SUMO1-GG. The resonances of some other residues (i.e., T451 and Q507, Fig. 2C and Supplementary Fig. 4) showed fast exchange between the free and bound states but with similar CSP trends. These data suggest that the β-grasp domain of SUMO1 interacts with SENP1 in a manner similar to that in the context of SUMO1-FL.
In contrast, the peptides corresponding to the C-terminus of SUMO1, S1-HSTV (residues 93-101, sequence of EQTGGHSTV) or S1-GG (residues 93-97 of SUMO1, sequence of EQTGG), did not produce CSP on SENP1 resonances upon titration into SENP1 (Fig. 2D). NMR CSP is the most sensitive method to detect weak interactions. This result indicates that the C-terminal segment of the substrate has a considerably low intrinsic affinity for the enzyme. Isothermal titration calorimetry (ITC) measurements confirmed this observation. Binding of SUMO11-92 to SENP1 resulted in significant heat release (Kd of 3.52 ± 0.081 μM, ΔH of -9.3 ± 0.14 kcal•mol-1 and ΔS of -6.3 cal•mol-1K-1), but the S1-GG or S1-HSTV peptides did not result in significant heat exchange, as shown by the representative ITC profile of S1-HSTV binding (Fig. 2E). Taken together, these data suggest that the β-grasp domain of SUMO1 is the main contributor to the binding affinity to SENP1, but the C-terminal region is not.
Although the C-terminal region of SUMO1 did not show detectable interaction with SENP1 by itself, NMR data indicates that this region does interact, weakly and in a dynamic fashion, with SENP1 in the context of the full-length substrate. The interaction of the C-terminal region was indicated by significant chemical shift changes of Trp534 Nε, a residue forming the bottom of the substrate binding channel at the catalytic center (Fig. 2F-G). The observed interaction, in contrast to the isolated S1-HSTV peptide, is unlikely due to an allosteric effect of the β-grasp domain because SUMO11-92 did not significantly enhance the binding of S1-GG or S1-HSTV peptides (Fig. 2E and 2G). Trp512 is located at the β-grasp domain-binding surface on SENP1, and significant chemical shift change of Trp512 Nε is observed upon binding SUMO1-FL as expected. The broadened line-width at Trp534 Nε resonance and the complete loss of Trp465 Nε resonance in the complex with SUMO1-FL in contrast to the strong resonance of Trp512 Nε (Fig. 2F), in combination with the intrinsic low affinity of the SUMO C-terminus for SENP1, suggest that the C-terminal region swayed between bound and unbound states while the β-grasp domain was bound. Additionally, the different line-broadening effects on the Trp465 and Trp534 Nε resonances (Fig. 2F), which form the top and bottom of the substrate binding channel respectively (Fig. 1A), indicate that Trp465 continues to undergo conformational exchange in the complex, possibly open-close dynamics, and not simply the closed conformation seen in SUMO-bound SENP1 crystal structures 12-14,28.
Effects of the SUMO1 β-grasp domain on SENP1
We mapped the CSP of SENP1 induced by binding SUMO11-92 onto the crystal structure of SENP1 (C603A) in complex with SUMO1-FL (PDB: 2IY1) (Fig. 3A). This revealed that substantial CSP are not localized to the direct interaction surface on SENP1 (Fig. 3A and Supplementary Figs. 4-5), but propagated to residues at the catalytic channel and beyond, such as Trp465-Asp468 and Leu530, Trp534, His533 and Ser603. In addition, we saw CSP of methyl groups that are not located at the direct contact surface for binding the β-grasp domain, indicating that the allosteric effect was propagated from the direct contact surface through the hydrophobic core (Fig. 3A). The CSPs at these regions suggest that the interaction with the β-grasp-fold domain of SUMO1 induced a structural allosteric effect that included the catalytic channel.
To confirm the allosteric effect from binding SUMO11-92, we measured 15N and 13C-methyl CPMG transverse relaxation dispersion for the partially SUMO11-92-bound complex 29,30. SUMO11-92-induced relaxation dispersion was measured at 20% SUMO11-92 occupancy, when the SENP1 resonances were not too broad to be measured accurately while significant relaxation dispersion could be observed. The partially bound state enhances CPMG relaxation dispersion and thus facilitates the observation of allosteric effect by SUMO11-92. As expected, the resonances of most residues at the direct binding interface of SUMO11-92 showed substantial CPMG dispersion, consistent with exchange between the free and the β-grasp domain bound states occurring on the μs-ms timescale (Fig. 3B-3E). The resonances of many residues that were not located at the direct binding surface, including the catalytic His533 and Val532, whose resonances only showed CPMG dispersion in the partially bound state (Fig. 3E), indicating a change of conformational states induced by the distally bound β-grasp domain. An area that showed significant Rex from CPMG dispersion measurements that were independent of complex formation contained the methyl group of Val516 and the backbone NH groups of residues 571-573 and 581-582 (Fig. 3B-3D). This area is not located at the direct binding surface for the β-grasp fold domain, but may contribute to the allosteric effect that propagates from the β-grasp binding surface to the catalytic channel.
Effect of the β-grasp domain on catalysis of SENP1
1H-chemical shifts are sensitive to non-covalent interactions. Intriguingly, the two closely positioned methyl groups of Val532 showed significantly different CSPs upon binding SUMO11-92; the γ2-methyl 1H of Val532 displayed an unusually large 1H-CSP (~0.1 ppm), but the γ1-methyl group showed a minimal 1H-CSP (Fig. 4A, left panel). The selective large CSP at only the γ2-methyl group is unlikely to be due to structural changes at Val532. The χ1 rotomeric distribution of Val532 in SENP1, both in the free and bound states, is estimated to be 90% gauche- state and 10% gauche+ state, based on the 13C-chemical shifts 28. This is consistent with published SENP1 crystal structures, in which Val532 was in the gauche- state 12,14. Therefore, the large 1H-CSP likely reflects structural changes of nearby residues. An aromatic ring current effect is the most likely contributor to 1H-CSP through non-covalent interactions. Two aromatic residues, His533 and Trp465, are adjacent to Val532. The program SHIFT×2 31 was used to analyze the effect of the distance-dependence of the aromatic ring current effect of His533 and Trp465 using available crystals structures to define possible structural changes. Changes in the Trp465 sidechain position were expected to cause similarly large 1H-CSP on both Val532 methyl groups because of their similar proximities to the Trp aromatic ring (Fig. 4B), but inconsistent with the observed 1H-CSP (Fig. 4A). However, changes in His533 position had a much larger effect on 1H-CSP of the γ2-methyl than the γ1 methyl of Val532, a pattern that agreed with the NMR data (Fig. 4A, left panel) and was consistent with the γ2-methyl facing His533 while the γ1-methyl was not (Fig. 4B). Therefore, the observed 1H-CSP at Val532 methyl (Fig. 4A) likely indicates a change in the His533 position from the free state (red structure, Fig. 4B) toward that represented by the complex state with a substrate (yellow structure, Fig. 4B). Further support that the γ2-methyl of Val532 is sensitive to changes in the catalytic residues came from substituting Cys603 with Ser, which also caused a much larger 1H-CSP at the γ2-methyl than at the γ1-methyl (Fig. 4A, right panel). The His533 aromatic ring is hydrogen-bonded to Cys603 through a water molecule 32,33, and thus it is conceivable that Cys to Ser substitution, which results in a change of O to S, would alter the hydrogen bound with the His533 aromatic ring that caused a shift in His533 position that corresponds to a larger 1H-CSP on the γ2-methyl than γ1-methyl. The His533 conformational change is likely enabled by its intrinsic flexibility, as indicated by its having one of the largest Rex,ρNε values (4.2 ± 0.2 s-1) (Fig. 1A). Additionally, His533 only showed significant CPMG dispersion when partially bound by SUMO11-92, supporting a conformational change at this site induced by binding of the β-grasp domain (Fig. 3B, 3C and 3E). Furthermore, the resonances of residues surrounding His533, i.e., Ser603 and Gly604, also displayed CSP and CPMG dispersion when partially bound with SUMO11-92 (Fig. 3A and 3B), which was consistent with realignment of the catalytic residues.
Based on the structural changes observed at the catalytic residues we hypothesized that the catalytic activity (kcat) of SENPs and possibly some DUBs would be affected upon binding the β-grasp-fold domains of their respective Ubls. To test this, we conducted steady-state enzymatic kinetic analysis of SENP1 and SENP1 that was saturated with SUMO11-92, using a bioluminescent-based assay and DUB-Glo (Promega) as a substrate (Fig. 4C). When saturated with SUMO11-92, SENP1 reproducibly had a higher apparent kcat value than did free SENP1; no significant changes in the apparent Km were seen. The lack of change in the apparent Km is consistent with the similarly small CSP and heat release generated by the S1-GG or S1-HSTV peptides on SENP1 and SENP1 in complex with SUMO11-92 (Figs. 2D, 2E and 2G). Saturation of a DUB, USP5, with the β-grasp domain of ubiquitin also enhanced the kcat (Fig. 4D). Unlike SENP1, Usp5 displayed significant changes in the apparent Km. This result also suggests an allosteric effect at the catalytic channel from binding the β-grasp domain of ubiquitin. Because the β-grasp domain of ubiquitin is expected to be responsible for the majority of the binding affinity, the increase in the Km with DUB-Glo could be insignificant in the context of the full-length substrates that contains the β-grasp domain of ubiquitin. Taken together, our findings suggest that conformational changes induced by the β-grasp domain optimize the catalytic residues for catalysis.
DISCUSSION
The data obtained in this study indicates that residues at the catalytic channel of SENP1 undergo motions over a wide range of timescales, both free and in complex with a substrate. Among residues in the catalytic channel, the dynamics of the “lid” residue, Trp465, were detected over the widest timescale from ps to ms, indicating its extensive flexibility. Therefore the catalytic channel undergoes extensive motions that allow substrates to bind into the seemingly closed channel (Fig. 1). This finding is unlikely affected by the C603S mutation, because the wild-type SENP1 also has weak intrinsic affinity for the C-terminal segment of SUMO1 that is not affected by binding SUMO11-92 (Supplementary Figs. 6 and 7). Trp465 undergoes extensive motions with and without interacting with SUMO-FL (Fig. 1 and Fig. 2F). The β-grasp domain more stably interacts with SENP1 than with the C-terminal region of SUMO1-FL, which appears to sway between bound and unbound states, while the β-grasp domain bound to SENP1 (Fig. 2F and Fig. 5). DUB-Glo, a pentapeptide substrate, can be cleaved by several Ubl-specific proteases in the Cys protease superfamily, even though its sequence is derived from the C-terminus of ubiquitin, which is different from the sequences of the C-terminal regions of other Ubls 34. Therefore, the lack of specificity of the Ubl-specific proteases to peptide substrates, such as DUB-Glo, suggests that the conformational flexibility at the catalytic channel, as we found for SENP1, likely represents a general property of the Ubl-specific proteases in the Cys protease superfamily.
NMR data suggest that the binding of the β-grasp domain of SUMO1 induces a structural change of the catalytic residues (Fig. 3 and Fig. 4). The structural changes induced by the β-grasp domain, as indicated by the selective 1H-CSP of the γ2-methyl of Val532, correspond to enhanced enzymatic turnover rate of SENP1 (Fig. 4 and Fig. 5). Previous biochemical data indicates that our conclusion is application to all SENPs35,36. This allosteric effect from the β-grasp domain that alters the catalytic residues likely occurs in some other Ubl-specific proteases that belong to the Cys protease superfamily, as suggested by enhanced catalysis of USP5 by the β-grasp domain of ubiquitin (Fig. 4D). These de-conjugation enzymes likely have high affinity for the β-grasp domain of their corresponding Ubls, such as SENPs and USP5. Our finding suggests that the previous finding that ubiquitin (not C-terminal truncated) enhances the activity of USP5 37 is due to the binding of the β-grasp domain of ubiquitin. The β-grasp domain-binding surface, not only is critical to substrate binding affinity, but also responsible for enhanced activity of the Ubl-specific protease. Therefore, targeting this allosteric site in Ubl-specific proteases could be more successful in producing specific inhibitors.
The role of protein-protein interactions in cellular signaling and the formation of biologically functional complexes is well appreciated. However, many proteins are also substrates for enzymes, such as those catalyzing conjugation and de-conjugation of Ubl modifications. The findings described here illustrate how a macromolecular substrate allosterically enhances the activity of its enzyme.
METHODS
Sample preparation
His-tagged unlabeled or 15N/13C-labeled WT or C603S SENP1 catalytic domain, and unlabeled Ubl β-grasp domains, SUMO11-92 (deleting EQTGG) and Ubiquitin1-71 (deleting RLRGG) were expressed and purified as described previously 38. To overexpress selectively methyl-labeled SENP1, E. coli BL21 (DE3) cells harboring the SENP1 plasmid were transferred into 250 mL of M9 media at 100% D2O that contained 0.25 g 15NH4Cl, 1 g D7-glucose, and sodium salts of 60 mg [methyl-13C; 3,3-D2]-alpha-ketobutyric, and 60 mg [3-methyl-13C; 3,4,4,4-D]-alpha-ketoisovaleric acid. The cells were grown for 1 hour at 37 °C prior to induction with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 24 hours at 15 °C. All NMR isotopes were obtained from Cambridge Isotope Laboratories. The His-tagged proteins were isolated from cell lysate by using Ni-NTA (Qiagen) chromatography.
The de-ubiquitin enzyme USP-5 was purchased from Boston Biochem and the SUMO1 C-terminus peptides, S1-HSTV (EQTGGHSTV) and S1-GG (EQTGG), were purchased from Peptide 2.0 Inc. The peptides were dissolved in D6-dimethyl sulfoxide (DMSO) to 20-30 mM, and their concentrations were calibrated by 1D 1H NMR using the standard DSS (4, 4-dimethyl-4-silapentane-1-sulfonic acid). In each experiment, less than 1%DMSO was introduced upon addition of the peptide and the equivalent amount of DMSO was added to record the reference spectra.
NMR titration
Protein samples were prepared at 0.25 mM in a buffer containing 20 mM sodium phosphate, pH 6.8, 5 mM DTT, 0.02 % NaN3, and 10 % D2O. Chemical shift assignments of WT SENP1 were obtained as previously described for C603S SENP1 (BMRB entry19083) 38. Backbone and side-chain methyl assignments used standard through-bond NMR experiments. Stereo-specific assignments of the methyls of Val and Leu were achieved using samples produced from M9 cultures containing 20% 13C6 glucose and 80% unlabeled glucose as the sole carbon source 39,40.
All titration experiments were performed at 298 K on a Bruker Avance 600 MHz spectrometer equipped by with a TXI cryoprobe. TROSY-type 1H-15N HSQC spectra and constant time 1H-13C HSQC for the methyl groups were collected for SENP1 and 1:1 SENP1-SUMO11-92 complex, without and with addition of 2.4-fold S1-HSTV and 2.7-fold S1-GG peptides. The titration experiments for SENP1 binding to the different SUMO1 constructs, SUMO1-FL, SUMO1-GG and SUMO11-92 were conducted at SENP1:SUMO1 molar ratios of 1:0, 1:0.2, 1:0.4, 1:0.6, 1:0.8, 1:1.07, and 1:1.39. NMR data was processed with NMRPipe 41, and spectra were analyzed using the program SPARKY 42. Chemical shift perturbations (CSP) for Fig. 3A were calculated as
[1] |
where, ΔδH, ΔδN, and ΔδC are the chemical shift differences between the free and bound states in the proton, nitrogen, and carbon dimensions, respectively.
15N relaxation measurements
TROSY-type 15N NMR relaxation experiments were performed using a [U-15N, 2H]-[Ile δ1(13CH3)-Leu, Val(13CH3, 12CD3)]-labeled SENP1(C603S) sample. 15N R1 and R2 relaxation rates and 1H-15N steady state NOE, were measured on 600 MHz Bruker spectrometer, with pulse shaping and pulsed field gradient capabilities as previously described 43. R1 data were recorded with relaxation delays of 100, 200 (× 2), 350, 500, 700 (×2), 900, 1100 ms, and R2 data were acquired using relaxation delays of 4.4, 8.8 (× 2), 17.6, 24.4, 35.2 (×2), 44, and 61.6 ms. Uncertainties were estimated from duplicate points. 1H-15N steady state NOE values were determined by collecting spectra in the presence and in the absence of 3 second proton saturation, which was applied before the start of the pulse sequence. To characterize microsecond motions 27, the decay rates of R1ρ(2Hz’Nz), R1ρ (2HzNz’) and R1ρ(2Hz’Nz’) were estimated with relaxation delays of 4, 6 (×2), 8, 12, 16, 20, 24 (×2), 28, 36 ms. R1(2HzNz) data was recorded using relaxation delays of 20, 30 (×2), 40, 60, 80, 100, 120 (×2), 140, 170 ms. R2(2HxNz), R2(2HzNx) and R2(2HxNx) values were converted with the equations described previously 27. The Rex contributed from microsecond motions was calculated as
[2] |
where dHN = (μ0/4π) ħγHγNrHN-3, cN = B0γNΔσN√((1 + ηN2 /3)/3), μ0 is the permeability of free space, ħ is the reduced Planck’s constant, γN and γH are the gyromagnetic ratios of 15N and 1H, respectively, rHN is the averaged bond length between 1H and 15N nuclei. B0 is the static magnetic field strength, ΔσN = σ11 - (σ22 + σ33)/2, (σ11, σ22, σ33) are the principle components of the nitrogen chemical shift anisotropy tensor, ηN = (σ22 - σ33)/(σ11 - σiso), and σiso = (σ11 + σ22 + σ33)/3.
15N-CPMG relaxation dispersion experiments for free SENP1 and SUMO11-92:SENP1 complex at 0.2:1 molar ratios were measured at 293 K on the Bruker Avance 600 and Ascend 700 spectrometers, using CPMG pulse sequence and phase cycling as previously described 29. Spectra were collected as a series of two-dimensional data sets with the field strengths, νCPMG, of 50, 100, 150, 200 (×2), 300, 400, 500 (×2), 600, 700, 800, and 1000 Hz. Repeated points were used for error analysis. Each spectrum had the same CPMG duration of 40 ms and a reference spectrum was obtained using the pulse sequence without the CPMG blocks.
Single-quantum 13C-methyl relaxation dispersion experiments for free SENP1 and SUMO11-92:SENP1 complex at 0.2:1 molar ratios were performed at 293 K using the same spectrometers and field strengths 30. Data was analyzed using the MATLAB software GUARDD, with the Carver-Richards-Jones equation and Monte Carlo bootstrap method for error estimation 44.
ITC measurements
ITC experiments were performed at 25 °C using a VP-ITC microcalorimeter (GE Healthcare) and with all samples buffer-matched in 50 mM Tris pH 8, 100 mM NaCl, and 0% or 0.5% DMSO. SUMO11-92 (790 μM) was titrated into the calorimetric cell with SENP1 (C603S) at 50 μM. S1-HSTV and S1-GG peptides at 1500 μM were titrated into the cell with SENP1 (C603S) or SENP1 (C603S) +SUMO11-92 (molar ratio 1:4.5), at 100 μM of SENP1 (C603S). Heats of dilution were obtained from repeating the titrations with buffer only in the calorimetric cell. Data was analyzed and fit to a single-binding site model using Origin software (Microcal).
DUB-Glo assay
The enzymatic reaction was performed in a total volume of 100 μl of Tris buffer (50 mM Tris, pH 8.0, and 10 mM DTT). The Z-RLRGG-Glo™ (DUB-glo) substrate in the Luciferin Detection Reagent (Promega) was mixed with WT SENP1 (final concentration 100 nM) or WT SENP1-SUMO11-92 complex (1:75 molar ratio) in a white 96-well plate at 0 to 130 μM final concentration. The molar ratio used for the complex was based on optimal concentrations that ensured SENP1 saturation (>70%) without aggregation. Similarly, the USP-5:Ubi (1:1500) was subjected to the same experimental procedure using 100 nM USP5. Triplicate experiments were carried out for error estimation. Luminescence was recorded at 25 °C and 30 min after the addition of the enzyme according to the recommendation from Promega. The correlation between the measured RLU (relative light unit) of fully cleaved DUB-glo substrate and the corresponding known substrate concentration was used to convert RLU to molar concentration. The data was analyzed using GraphPad Prism software and was fit to the Michaelis-Menten kinetics model with nonlinear regression.
Supplementary Material
Acknowledgments
The studies were supported by NIH grants (GM102538 and GM086171). We thank the NMR Core facility at City of Hope for support.
Footnotes
Author Contributions: Designed experiments or supervised the study: Y.C., C.-H. C. Performed the experiments, analyzed the data or prepared tables and figures: Y.C., C.-H.C., and A.T.N. Wrote the manuscript: Y.C., C.-H.C., and A.T.N.
Accession codes: Chemical shift assignments for wild-type SENP1 catalytic domain have been deposited in the Biological Magnetic Resonance Bank under the accession code 19885.
References
- 1.Kerscher O, Felberbaum R, Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol. 2006;22:159–80. doi: 10.1146/annurev.cellbio.22.010605.093503. [DOI] [PubMed] [Google Scholar]
- 2.Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta. 2004;1695:189–207. doi: 10.1016/j.bbamcr.2004.10.003. [DOI] [PubMed] [Google Scholar]
- 3.Sarge KD, Park-Sarge OK. Sumoylation and human disease pathogenesis. Trends Biochem Sci. 2009;34:200–5. doi: 10.1016/j.tibs.2009.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Yeh ET. SUMOylation and De-SUMOylation: wrestling with life’s processes. J Biol Chem. 2009;284:8223–7. doi: 10.1074/jbc.R800050200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hay RT. SUMO: a history of modification. Mol Cell. 2005;18:1–12. doi: 10.1016/j.molcel.2005.03.012. [DOI] [PubMed] [Google Scholar]
- 6.Schulz S, et al. Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions. EMBO Rep. 2012;13:930–8. doi: 10.1038/embor.2012.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Yeh ET, Gong L, Kamitani T. Ubiquitin-like proteins: new wines in new bottles. Gene. 2000;248:1–14. doi: 10.1016/s0378-1119(00)00139-6. [DOI] [PubMed] [Google Scholar]
- 8.Johnston SC, Larsen CN, Cook WJ, Wilkinson KD, Hill CP. Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution. EMBO J. 1997;16:3787–96. doi: 10.1093/emboj/16.13.3787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Butterworth MB, et al. The deubiquitinating enzyme UCH-L3 regulates the apical membrane recycling of the epithelial sodium channel. J Biol Chem. 2007;282:37885–93. doi: 10.1074/jbc.M707989200. [DOI] [PubMed] [Google Scholar]
- 10.Reverter D, Lima CD. A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. Structure. 2004;12:1519–31. doi: 10.1016/j.str.2004.05.023. [DOI] [PubMed] [Google Scholar]
- 11.Reverter D, Lima CD. Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates. Nat Struct Mol Biol. 2006;13:1060–8. doi: 10.1038/nsmb1168. [DOI] [PubMed] [Google Scholar]
- 12.Shen L, et al. SUMO protease SENP1 induces isomerization of the scissile peptide bond. Nat Struct Mol Biol. 2006;13:1069–77. doi: 10.1038/nsmb1172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Shen LN, Dong C, Liu H, Naismith JH, Hay RT. The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing. Biochem J. 2006;397:279–88. doi: 10.1042/BJ20052030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Xu Z, et al. Crystal structure of the SENP1 mutant C603S-SUMO complex reveals the hydrolytic mechanism of SUMO-specific protease. Biochem J. 2006;398:345–52. doi: 10.1042/BJ20060526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lima CD, Reverter D. Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. J Biol Chem. 2008;283:32045–55. doi: 10.1074/jbc.M805655200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hu M, et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 2002;111:1041–54. doi: 10.1016/s0092-8674(02)01199-6. [DOI] [PubMed] [Google Scholar]
- 17.Hu M, et al. Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J. 2005;24:3747–56. doi: 10.1038/sj.emboj.7600832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell. 2007;131:584–95. doi: 10.1016/j.cell.2007.08.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Xu Y, et al. Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis. J Biol Chem. 2010 doi: 10.1074/jbc.M110.164236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Cheng J, Bawa T, Lee P, Gong L, Yeh ET. Role of desumoylation in the development of prostate cancer. Neoplasia. 2006;8:667–76. doi: 10.1593/neo.06445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Bawa-Khalfe T, Cheng J, Lin SH, Ittmann MM, Yeh ET. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem. 2010;285:25859–66. doi: 10.1074/jbc.M110.134874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kaikkonen S, et al. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. Mol Endocrinol. 2009;23:292–307. doi: 10.1210/me.2008-0219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Goldenberg SJ, McDermott JL, Butt TR, Mattern MR, Nicholson B. Strategies for the identification of novel inhibitors of deubiquitinating enzymes. Biochem Soc Trans. 2008;36:828–32. doi: 10.1042/BST0360828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wang Q, et al. SUMO-specific protease 1 promotes prostate cancer progression and metastasis. Oncogene. 2012 doi: 10.1038/onc.2012.250. [DOI] [PubMed] [Google Scholar]
- 25.Xu Y, et al. SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors. Cancer Letters. 2011;309:78–84. doi: 10.1016/j.canlet.2011.05.019. [DOI] [PubMed] [Google Scholar]
- 26.Albrow VE, et al. Development of small molecule inhibitors and probes of human SUMO deconjugating proteases. Chem Biol. 2011;18:722–32. doi: 10.1016/j.chembiol.2011.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hansen DF, Feng H, Zhou Z, Bai Y, Kay LE. Selective characterization of microsecond motions in proteins by NMR relaxation. J Am Chem Soc. 2009;131:16257–65. doi: 10.1021/ja906842s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Hansen DF, Kay LE. Determining Valine Side-Chain Rotamer Conformations in Proteins from Methyl (13)C Chemical Shifts: Application to the 360 kDa Half-Proteasome. J Am Chem Soc. 2011;133:8272–81. doi: 10.1021/ja2014532. [DOI] [PubMed] [Google Scholar]
- 29.Long D, Liu ML, Yang DW. Accurately probing slow motions on millisecond timescales with a robust NMR relaxation experiment. Journal of the American Chemical Society. 2008;130:2432–2433. doi: 10.1021/ja710477h. [DOI] [PubMed] [Google Scholar]
- 30.Lundstrom P, Vallurupalli P, Religa TL, Dahlquist FW, Kay LE. A single-quantum methyl C-13-relaxation dispersion experiment with improved sensitivity. Journal of Biomolecular Nmr. 2007;38:79–88. doi: 10.1007/s10858-007-9149-7. [DOI] [PubMed] [Google Scholar]
- 31.Han B, Liu Y, Ginzinger SW, Wishart DS. SHIFTX2: significantly improved protein chemical shift prediction. J Biomol NMR. 2011;50:43–57. doi: 10.1007/s10858-011-9478-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Das C, et al. Structural basis for conformational plasticity of the Parkinson’s disease-associated ubiquitin hydrolase UCH-L1. Proc Natl Acad Sci U S A. 2006;103:4675–80. doi: 10.1073/pnas.0510403103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Shi T, et al. Exploring the Desumoylation Process of SENP1: A Study Combined MD Simulations with QM/MM Calculations on SENP1-SUMO1-RanGAP1. J Chem Inf Model. 2013 doi: 10.1021/ci4002487. [DOI] [PubMed] [Google Scholar]
- 34.Madu IG, et al. Identification and Characterization of a New Chemotype of Noncovalent SENP Inhibitors. ACS Chem Biol. 2013 doi: 10.1021/cb400177q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Mikolajczyk J, et al. Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs. J Biol Chem. 2007;282:26217–24. doi: 10.1074/jbc.M702444200. [DOI] [PubMed] [Google Scholar]
- 36.Drag M, Mikolajczyk J, Krishnakumar IM, Huang Z, Salvesen GS. Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family. Biochem J. 2008;409:461–9. doi: 10.1042/BJ20070940. [DOI] [PubMed] [Google Scholar]
- 37.Drag M, et al. Positional-scanning fluorigenic substrate libraries reveal unexpected specificity determinants of DUBs (deubiquitinating enzymes) Biochem J. 2008;415:367–75. doi: 10.1042/BJ20080779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Madu IG, et al. Identification and characterization of a new chemotype of noncovalent SENP inhibitors. ACS Chem Biol. 2013;8:1435–41. doi: 10.1021/cb400177q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hu W, Zuiderweg ER. Stereospecific assignments of Val and Leu methyl groups in a selectively 13C-labeled 18 kDa polypeptide using 3D CT-(H) CCH-COSY and 2d 1Jc-c edited heteronuclear correlation experiments. J Magn Reson B. 1996;113:70–5. doi: 10.1006/jmrb.1996.0157. [DOI] [PubMed] [Google Scholar]
- 40.Neri D, Szyperski T, Otting G, Senn H, Wuthrich K. Stereospecific Nuclear Magnetic-Resonance Assignments of the Methyl-Groups of Valine and Leucine in the DNA-Binding Domain of the 434-Repressor by Biosynthetically Directed Fractional C-13 Labeling. Biochemistry. 1989;28:7510–7516. doi: 10.1021/bi00445a003. [DOI] [PubMed] [Google Scholar]
- 41.Delaglio F, et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6:277–93. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
- 42.Goddard TD, Kneller DG. SPARKY 3. University of California; San Francisco: [Google Scholar]
- 43.Zhu G, Xia Y, Nicholson LK, Sze KH. Protein dynamics measurements by TROSY-based NMR experiments. J Magn Reson. 2000;143:423–6. doi: 10.1006/jmre.2000.2022. [DOI] [PubMed] [Google Scholar]
- 44.Kleckner IR, Foster MP. GUARDD: user-friendly MATLAB software for rigorous analysis of CPMG RD NMR data. Journal of Biomolecular Nmr. 2012;52:11–22. doi: 10.1007/s10858-011-9589-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.